Gene Patents and Collaborative Licensing Models 2009
DOI: 10.1017/cbo9780511581182.014
|View full text |Cite
|
Sign up to set email alerts
|

Open source genetics. Conceptual framework

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…On the one hand, the advocacy of access is often described in terms of knowledge commons, or intellectual commons revolving around the successful management of common-pool resources (see Burk 2002 ;Boettiger and Burk 2004 ;Opderbeck 2004 ;Allarakhia and Wensley 2007 ;Overwalle 2009 ;Hope 2008Hope , 2009. This includes occasional references to enclosure in an historical analogy to Marx's description of the enclosure of the English commons (see Harvey 2011 ), for instance in James Boyle's 'second enclosure movement' and Christopher May's 'new enclosures' ( May 2000 ;Boyle 2003aBoyle , 2003bBoyle , 2008.…”
Section: The Transformation Of Global Governancementioning
confidence: 99%
“…On the one hand, the advocacy of access is often described in terms of knowledge commons, or intellectual commons revolving around the successful management of common-pool resources (see Burk 2002 ;Boettiger and Burk 2004 ;Opderbeck 2004 ;Allarakhia and Wensley 2007 ;Overwalle 2009 ;Hope 2008Hope , 2009. This includes occasional references to enclosure in an historical analogy to Marx's description of the enclosure of the English commons (see Harvey 2011 ), for instance in James Boyle's 'second enclosure movement' and Christopher May's 'new enclosures' ( May 2000 ;Boyle 2003aBoyle , 2003bBoyle , 2008.…”
Section: The Transformation Of Global Governancementioning
confidence: 99%
“…For example, her aim is to discuss the ‘generic open source principles and the realities of biotechnology research and development’ (ibid.). From this point of view, open source is a possible solution to what she calls an ‘innovation lock down’ – as a solution to this problem, she has proposed that ‘open source principles might be translated into a new context; that of biotechnology and its close industrial relations, pharmaceuticals and agriculture’ (Hope , 1, 18; see also Hope ).…”
Section: The Availability Of Dna In Any Formatmentioning
confidence: 99%
“…Along with the notoriety of the restrictions on the usage of plants, a particularly heated topic of discussion revolves around the question of whether the patenting of DNA is discouraging innovation in the life sciences (see Heller ; Heller and Eisenberg ; Boyle ,b). There is no need to settle this question, however, when observing solely that the patenting of DNA has been accompanied by an extensive trading and cross‐licensing of patents, as well as the arrangement of open access in collaborative research projects, joint ventures, private consortia or public–private partnerships (see Burk ; Reichman and Uhlir ; Boettiger and Burk ; Hope , , ; Opderbeck ; Allarakhia and Wensley , 1486; Allarakhia ; Allarakhia and Wensley ; Overwalle ; Rai and Boyle ).…”
Section: Introductionmentioning
confidence: 99%
“…The core principles and objectives of open source must therefore be identified. Hope () lists three objectives of open source licensing: credible commitment, competition and optionally, copyleft. Credible commitment requires the technology to be protected by IPRs, so when distributed the license is legally enforceable.…”
Section: Introductionmentioning
confidence: 99%
“…In the case where the licensor imposes requirements on the licensee, then the license is not open source. Finally, Hope () explains that in life science, copyleft is akin to grant‐back and reach‐through mechanisms also known as “passing it forward” (p. 183). In order for a license to be qualified as reciprocal or copyleft, the licensor must not retain rights to improvements to the original technology.…”
Section: Introductionmentioning
confidence: 99%